Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Akerman

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
The Biochemical Journal|February 1, 1993
Inhibition of inositol 1,4,5-trisphosphate 5-phosphatase by micromolar concentrations of disulfiram and its analoguesC J Fowler, G Brännström, P C Ahlgren, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression systemJ P Kukkonen, J Näsman, P Ojala, et al.
FEBS Letters|August 4, 1998
Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signalingK E Akerman, J Näsman, P E Lund, et al.
Current Protocols in Neuroscience|April 23, 2008
Measurement of chloride movement in neuronal preparationsR D Schwartz-Bloom, A C Engblom, K E Akerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blottingJ Kukkonen, P Ojala, J Näsman, et al.
Journal of Cellular Physiology|August 1, 1986
Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cellsI G Scott, K E Akerman, J E Heikkilä, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2002
Nanocrystal targeting in vivoMaria E Akerman, Warren C W Chan, Pirjo Laakkonen, et al.
Monographs in Neural Sciences|January 1, 1980
Does rigidity in structure of muscarinic agonists and antagonists reflect drug specificity?A Fisher, S Abraham, C Lachman, et al.
Experimental Cell Research|September 1, 1993
Ca2+ and Zn2+ dependence of DNA synthesis in untransformed and in Ha-ras(val-12)-expressing NIH 3T3 cellsC J Back, L Sistonen, M O Enkvist, et al.
European Journal of Pharmacology|January 15, 1994
Coupling of human alpha 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cellsC C Jansson, A Marjamäki, K Luomala, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
The Biochemical Journal|February 1, 1993
Inhibition of inositol 1,4,5-trisphosphate 5-phosphatase by micromolar concentrations of disulfiram and its analoguesC J Fowler, G Brännström, P C Ahlgren, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression systemJ P Kukkonen, J Näsman, P Ojala, et al.
FEBS Letters|August 4, 1998
Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signalingK E Akerman, J Näsman, P E Lund, et al.
Current Protocols in Neuroscience|April 23, 2008
Measurement of chloride movement in neuronal preparationsR D Schwartz-Bloom, A C Engblom, K E Akerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blottingJ Kukkonen, P Ojala, J Näsman, et al.
Journal of Cellular Physiology|August 1, 1986
Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cellsI G Scott, K E Akerman, J E Heikkilä, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2002
Nanocrystal targeting in vivoMaria E Akerman, Warren C W Chan, Pirjo Laakkonen, et al.
Monographs in Neural Sciences|January 1, 1980
Does rigidity in structure of muscarinic agonists and antagonists reflect drug specificity?A Fisher, S Abraham, C Lachman, et al.
Experimental Cell Research|September 1, 1993
Ca2+ and Zn2+ dependence of DNA synthesis in untransformed and in Ha-ras(val-12)-expressing NIH 3T3 cellsC J Back, L Sistonen, M O Enkvist, et al.
European Journal of Pharmacology|January 15, 1994
Coupling of human alpha 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cellsC C Jansson, A Marjamäki, K Luomala, et al.
Pageof 16